(Q37627645)

21 August 2017

1 reference

title

Single HCC smaller than 2 cm: surgery or ablation: interventional oncologist's perspective (English)

1 reference

21 August 2017

main subject

hepatocellular carcinoma

1 reference

Tito Livraghi

1

1 reference

21 August 2017

publication date

5 November 2009

1 reference

Journal of Hepato-biliary-Pancreatic Sciences

21 August 2017

published in

1 reference

21 August 2017

volume

17

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

425-429

1 reference

Management of hepatocellular carcinoma

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Pathology of small hepatocellular carcinoma. A proposal for a new gross classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Early hepatocellular carcinoma as an entity with a high rate of surgical cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

Surgical therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-009-0244-X

10.1007/S00534-009-0244-X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference